搜索临床试验以:Tozadenant (SYN115) 120 毫克 BID
总计2364个结果
-
Biotie Therapies Inc.终止
-
Vifor (International) Inc.Labcorp Drug Development Inc撤销
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany完全的
-
University Medical Centre LjubljanaUniversity of Ljubljana School of Medicine, Slovenia完全的
-
Institute of Hematology & Blood Diseases Hospital尚未招聘鲁索替尼对 AA HSCT 受者的 aGVHD 的预防价值
-
Bristol-Myers Squibb完全的
-
Merck Sharp & Dohme LLC完全的人类免疫缺陷病毒 1 (HIV-1)
-
Janssen Research & Development, LLC完全的
-
Ipsen招聘中
-
Suzhou Kintor Pharmaceutical Inc,Suzhou Koshine Biomedica, Inc.主动,不招人
-
Vifor (International) Inc.Fortrea完全的
-
University Medical Centre LjubljanaMedical University of Vienna; Harvard University; University of Ljubljana School of Medicine,...未知
-
N-Gene Research Laboratories, Inc.Thermo Fisher Scientific, Inc; Integrium; Msource Medical Development GmbH; Kinexum LLC; Haupt Pharma... 和其他合作者终止
-
Biotie Therapies Inc.Acorda Therapeutics终止
-
University of JenaNovartis Pharmaceuticals; Ludwig-Maximilians - University of Munich主动,不招人
-
Eisai Inc.主动,不招人乳腺肿瘤 | 受体,雌激素 | 基因,Erbb-2美国, 英国
-
AstraZeneca招聘中哮喘美国, 加拿大, 南非, 大韩民国, 菲律宾, 捷克语, 马来西亚, 德国
-
Biotie Therapies Inc.National Institute on Drug Abuse (NIDA)完全的